STOCKWATCH
·
Pharmaceuticals
Board Meeting11 Mar 2026, 06:33 pm

Venmax Drugs and Pharmaceuticals Ltd Changes Designation of Director to Managing Director for 5 Years

AI Summary

Venmax Drugs and Pharmaceuticals Ltd has announced the change in designation of Mr. Venkata Rao Sadhanala from Whole Time Director to Managing Director for a period of 5 years, effective from March 11, 2026. The appointment is subject to the approval of the shareholders in the next General Meeting. Mr. Sadhanala, a Qualified Chartered Accountant and Company Secretary, has over 3 decades of experience in the Banking and Finance & FMCG and Pharma Industry. He will be paid a remuneration of Rs. 30 lakhs p.a including perquisites.

Key Highlights

  • Mr. Venkata Rao Sadhanala's designation changed from Whole Time Director to Managing Director
  • The change is effective from March 11, 2026, for a period of 5 years
  • The appointment is subject to shareholders' approval in the next General Meeting
  • Mr. Sadhanala has over 3 decades of experience in Banking and Finance & FMCG and Pharma Industry
  • He will be paid a remuneration of Rs. 30 lakhs p.a including perquisites
VENMAX
Pharmaceuticals
Venmax Drugs And Pharmaceuticals Ltd

Price Impact